Insights on Discovery
-
The Immune System's Secret Language: Unlocking Cellular Communication
10/15/2025
The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.
-
Measuring AAV Vector Genome Titer Using Droplet Digital PCR Protocol
10/6/2025
Achieve highly consistent and precise AAV vector genome titer measurements with this optimized ddPCR protocol. This method ensures accurate dosing and optimal cell therapy potency.
-
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays
9/25/2025
Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.
-
Use Of Epiontis ID In A Phase 2 Psoriasis Trial
9/25/2025
Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.
-
How AI & Biomarkers Are Reshaping The Next Frontier In Drug Development
9/18/2025
Learn more about the importance of biomarker-driven drug development and the integration of laboratory science, clinical expertise, and regulatory strategy to accelerate targeted therapy development.
-
Enhancing Throughput And Reproducibility In Proteomic Analysis
8/27/2025
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis
8/27/2025
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Variant-Aware Off-Target Analysis For Informed Guide RNA Selection
8/5/2025
See how a multi-step, variant-aware approach to CRISPR-based guide RNA selection systematically reduces off-target risk at each stage, giving researchers greater confidence in their work.
-
ASCO 2025: Key Takeaways From The American Society Of Clinical Oncology Annual Meeting
7/31/2025
Cell and gene therapy for cancer continues to advance. New data show promise, alongside discussions on safety and scalability.
-
Detection Of Rare And Low-Expressing BCMA CAR-T Cells
7/31/2025
Discover how precise flow cytometric identification of CAR+ cells across diverse models and workflows enables high specificity, flexibility, and sensitivity—even in rare or low-expression populations.